In 1610, Galileo turned his telescope towards Jupiter and made several remarkable observations
Generally, for medications like Wegovy and Zepbound, which are approved for weight management, individuals must have a Body Mass Index (BMI) of 30 kg/m or greater (considered obese), or a BMI of 27 kg/m or greater (considered overweight) along with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol
JANUMET is not recommended in patients with eGFR between 30 and less than 45 mL/min/1.73 m2
Reflux and gastroparesis considerations Because GLP-1 medications slow gastric emptying, they can worsen symptoms in some people who already have reflux, severe indigestion, or suspected gastroparesis
This "lean and strong" approach is at the heart of our philosophy
This is why so many of us have been intrigued by two medications making headlines for weight loss: Semaglutide and Tirzepatide